ProMis Neurosciences, Inc
Nasdaq PMN · Toronto, Ontario, Canada
Works in Neurology · Psychiatry
ProMis Neurosciences, Inc is a clinical trial sponsor based in Toronto, Ontario, Canada, listed as Nasdaq PMN. It has 1 active clinical trial with 144 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq PMN
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about ProMis Neurosciences, Inc
ProMis Neurosciences, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 144 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 1 trial and stopped 0 early.
ProMis Neurosciences, Inc is based in Toronto, Ontario, Canada and is listed as Nasdaq PMN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ProMis Neurosciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-13.
Approve Suite is not affiliated with ProMis Neurosciences, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.